110 filings
Page 4 of 6
S-4
76p6npo6a
15 Mar 22
Registration of securities issued in business combination transactions
4:38pm
425
xn785zrss 0lvofsl3o4
15 Mar 22
Business combination disclosure
4:34pm
8-K
d9p6dbi0jzb 2jxw
15 Mar 22
Regulation FD Disclosure
4:31pm
CORRESP
uos70mei
15 Mar 22
Correspondence with SEC
12:00am
8-K/A
6tc3x0obgtnnm 43t3
7 Mar 22
Index to Financial Statement
6:02pm
425
2nldl zeb
7 Mar 22
Business combination disclosure
9:01am
425
d7gvl1vzbga8
22 Feb 22
Business combination disclosure
4:48pm
8-K
bdaep5ah
22 Feb 22
Developing Cutting - Edge Treatments for Debilitating Fibrotic and Neurodegenerative Diseases Corporate Presentation February 2022MB0
4:43pm
UPLOAD
6si8v6gxw067gtf zx
26 Jan 22
Letter from SEC
12:00am
425
w2wg 36nqok4akmm
12 Jan 22
Business combination disclosure
8:33am
8-K
n5q6vl
12 Jan 22
Developing Cutting - Edge Treatments for Debilitating Fibrotic and Neurodegenerative Diseases January 2022
8:31am
425
dmk644
3 Jan 22
Business combination disclosure
8:32am
8-K
oop0ebnf9fg8wg
3 Jan 22
Biotech Acquisition Company Announces Confidential Submission of Registration Statement on Form S-4
8:30am
DRS
9zfzq2
27 Dec 21
Draft registration statement
12:00am
425
pe6bft9
30 Nov 21
Business combination disclosure
4:02pm
8-K
uvyy4e 01jeakd86
17 Nov 21
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:00am
NT 10-Q
2wq2nvgxpjjfd5qs2v
15 Nov 21
Notice of late quarterly filing
12:00am
425
rev51t
9 Nov 21
Business combination disclosure
5:10pm